Sub-Total: $0.00 USD
INDIGO Press Releases
Catch up on the latest news and announcements from INDIGO Biosciences.
INDIGO Biosciences Expands Reporter Assay Capabilities with New Transrepression Assay Services
New service offering enables GR/NF-κB transrepression studies to support deeper mechanism-of-action insight in drug discovery programsSTATE COLLEGE, PA (May 5th, 2026) – INDIGO Biosciences today announced the launch of its Transrepression Assay Services, expanding the company’s cell-based reporter assay capabilities for drug discovery teams studying pathway cross-talk, selective modulation, and transcription factor-mediated gene suppression.This new…
INDIGO Biosciences Launches GPR39 Reporter Assay for Metabolic, Gastrointestinal, and Inflammatory Disease Research
New Cell-Based Assay Supports Drug Discovery Targeting Glucose Homeostasis, Barrier Integrity, and Tissue RepairState College, PA (April 14th, 2026) – INDIGO Biosciences, a leading provider of cell-based reporter assay solutions, has announced the launch of its Human GPR39 Reporter Assay. The launch reflects INDIGO’s continued strategy of delivering assays for emerging and relevant drug targets,…
INDIGO Biosciences Introduces Metabolism-Dependent Safety Screening Services for Early, Human-Relevant Risk Assessment
Human hepatocyte co-culture paired with functional assays helps researchers determine whether metabolism changes biological activity.State College, PA (April 10th, 2026) – INDIGO Biosciences, a provider of cell-based reporter assay solutions, is expanding its service portfolio with Metabolism-Dependent Safety Screening, an approach designed to help researchers evaluate whether metabolic transformation changes a compound’s biological activity or…
INDIGO Biosciences Achieves Record Revenue in 2025
Performance driven by core drug discovery, continued adoption in environmental toxicology, and launch of new assays and a stable reporter cell line platform.State College, PA (March 31, 2026) – INDIGO Biosciences, a leading provider of innovative cell-based reporter assays and related technologies, announced today that the company achieved record revenue in 2025 marking the strongest…
INDIGO Biosciences Launches CHRM1 (Cholinergic Receptor, Muscarinic 1) Reporter Assays for CNS and Cognitive Drug Discovery
New Assay Expands INDIGO’s GPCR Portfolio and Supports Development of Next-Generation CNS-Related TherapeuticsState College, PA (March 19th, 2026) -INDIGO Biosciences, a leading provider of cell-based reporter assay solutions, today announced the launch of its Human Cholinergic Receptor, Muscarinic 1 (CHRM1) Reporter Assays. Available in both Activation and Inhibition formats, the assays enable researchers to evaluate…
INDIGO Biosciences Launches PrRPR/GPR10 Reporter Assay for Metabolic, Neuroendocrine, and Cardiometabolic Research
New Cell-Based Assay Supports Drug Discovery Targeting Appetite Regulation, Stress Biology, and Autonomic FunctionState College, PA (February 19, 2026) – INDIGO Biosciences, a premier provider of cell-based reporter assay solutions, has announced the launch of its Human Prolactin-Releasing Peptide Receptor (PrRPR/GPR10) Reporter Assay. This new assay provides researchers with a robust, ready-to-use platform for studying…
INDIGO Biosciences Launches AMY1 and AMY3 Receptor Reporter Assays for Metabolic and Neuroendocrine Research
New Cell-Based Assays Support Drug Discovery Across the Amylin Receptor FamilyState College, PA (January 15, 2026) – INDIGO Biosciences, a premier provider of cell-based reporter assay solutions, has announced the launch of its Human Amylin Type 1 Receptor (AMY1R) Reporter Assay and Human Amylin Type 3 Receptor (AMY3R) Reporter Assay. Together, these new assays provide…
INDIGO Biosciences Launches Melanocortin Receptor Reporter Assay Family
Suite of MCR Assays Enables Targeted Drug Discovery Across MC1R, MC2R, MC3R, MC4R, and MC5R ReceptorsState College, PA (26 August 2025) – INDIGO Biosciences, a leader in cell-based assay solutions, has announced the launch of its complete Melanocortin Receptor (MCR) Reporter Assay family, including MC1R, MC2R, MC3R, MC4R, and MC5R assays. This suite of assays…
INDIGO Biosciences Expands Alternative Species Portfolio with Six New Receptor Assays for Cross-Species Drug Screening
Pig Assay Joins Industry-Leading Catalog, Supporting Translational and Comparative ResearchState College, PA – [July 29, 2025] – INDIGO Biosciences, a global leader in cell-based assay solutions, announced today the expansion of its alternative species line with the launch of six new luciferase-based reporter assays: Dog Progesterone Receptor (PGR), Dog Androgen Receptor (AR), Dog Glucocorticoid Receptor…
INDIGO Biosciences Significantly Expands Portfolio with Launch of Stable Reporter Cell Lines for Drug Discovery and Toxicology Research
State College, PA – [May 13th, 2025] – INDIGO Biosciences, a global leader in cell-based assay solutions, announced today a significant expansion to its product portfolio with the launch of proprietary Stable Reporter Cell Lines. INDIGO’s new Stable Reporter Cell Lines are an industry-leading tool for long-term drug discovery projects and provide researchers with a…